DIA has announced the appointment of Dr Ling Su as President of the DIA Board of Directors. Su is Senior Vice President and Head of Development Greater China Region of Beijing Novartis Pharma Co. He is also an adjunct professor in the School of Pharmacy at Fudan University in Shanghai.
Su has more than 20 years of experience to DIA, specifically in the areas of regulatory affairs, clinical research and development, R&D strategies, pharmacovigilance, pharmacoepidemiology, and outcomes research.
“Through my years of service in the industry, as an active DIA volunteer for 20 years, and now as DIA Board President, I plan on sharing my insight to help DIA and the industry overcome the challenges that we collectively face,” says Su.
Su has served as chair of the DIA Provisional Advisory Council of China and received the DIA Outstanding Service Award in 2000.
EP News Bureau